Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Craig

Showing results (221-230 of 321) with videos related to

Pageof 33
Sort By:
Pediatrics|December 13, 2016
Management of Children With Hereditary Angioedema Due to C1 Inhibitor DeficiencyMichael M Frank, Bruce Zuraw, Aleena Banerji, et al.
Frontiers in Neurology|June 13, 2022
Guillain-Barré Syndrome in Patient With SARS-CoV-2 PCR Positivity Treated Successfully With Therapeutic Exchange Plasma: A First Case Report From VietnamSy Duong-Quy, Duc Huynh-Truong-Anh, Thanh Nguyen-Thi-Kim, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 30, 2011
Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trialWilliam R Lumry, H Henry Li, Robyn J Levy, et al.
Risk Management and Healthcare Policy|December 2, 2020
Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global PandemicNandeeta Samad, Temitayo Eniola Sodunke, Hasan Al Banna, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 12, 2016
Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry DataMarc A Riedl, Anette Bygum, William Lumry, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 9, 2026
Donidalorsen for hereditary angioedema: Long-term results from a 4-year phase 2 open-label extension studyMichael E Manning, Mats de Lange, Jonathan A Bernstein, et al.
Behavioural Brain Research|March 13, 2017
Peri-adolescent asthma symptoms cause adult anxiety-related behavior and neurobiological processes in miceJasmine I Caulfield, Michael J Caruso, Kerry C Michael, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2025
Hereditary Angioedema With Normal C1 Inhibitor: A Quarter Century of Forward Progress and Persisting ObstaclesSandra C Christiansen, Aleena Banerji, Jonathan A Bernstein, et al.
Pulmonary Therapy|April 15, 2022
The Use of Therapeutic Plasma Exchange in the Treatment of a Pregnant Woman with COVID-19 Induced Acute Respiratory Distress SyndromeSy Duong-Quy, Duc Huynh-Truong-Anh, Thanh Nguyen-Thi-Kim, et al.
Clinical and Translational Allergy|October 19, 2017
An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extensionMarc A Riedl, Jonathan A Bernstein, Timothy Craig, et al.
Pageof 33

Showing results (221-230 of 321) with videos related to

Sort By:
Pageof 33
Pediatrics|December 13, 2016
Management of Children With Hereditary Angioedema Due to C1 Inhibitor DeficiencyMichael M Frank, Bruce Zuraw, Aleena Banerji, et al.
Frontiers in Neurology|June 13, 2022
Guillain-Barré Syndrome in Patient With SARS-CoV-2 PCR Positivity Treated Successfully With Therapeutic Exchange Plasma: A First Case Report From VietnamSy Duong-Quy, Duc Huynh-Truong-Anh, Thanh Nguyen-Thi-Kim, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 30, 2011
Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trialWilliam R Lumry, H Henry Li, Robyn J Levy, et al.
Risk Management and Healthcare Policy|December 2, 2020
Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global PandemicNandeeta Samad, Temitayo Eniola Sodunke, Hasan Al Banna, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 12, 2016
Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry DataMarc A Riedl, Anette Bygum, William Lumry, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 9, 2026
Donidalorsen for hereditary angioedema: Long-term results from a 4-year phase 2 open-label extension studyMichael E Manning, Mats de Lange, Jonathan A Bernstein, et al.
Behavioural Brain Research|March 13, 2017
Peri-adolescent asthma symptoms cause adult anxiety-related behavior and neurobiological processes in miceJasmine I Caulfield, Michael J Caruso, Kerry C Michael, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2025
Hereditary Angioedema With Normal C1 Inhibitor: A Quarter Century of Forward Progress and Persisting ObstaclesSandra C Christiansen, Aleena Banerji, Jonathan A Bernstein, et al.
Pulmonary Therapy|April 15, 2022
The Use of Therapeutic Plasma Exchange in the Treatment of a Pregnant Woman with COVID-19 Induced Acute Respiratory Distress SyndromeSy Duong-Quy, Duc Huynh-Truong-Anh, Thanh Nguyen-Thi-Kim, et al.
Clinical and Translational Allergy|October 19, 2017
An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extensionMarc A Riedl, Jonathan A Bernstein, Timothy Craig, et al.
Pageof 33